New Patent Issued to ImmuDyne by the U.S. Patent Office (PinkSheets:IMMD)

Source: ImmuDyne, Inc.

New Patent Issued to ImmuDyne by the U.S. Patent Office

FLORENCE, Ky., June 30, 2009 (GLOBE NEWSWIRE) -- ImmuDyne (Pink Sheets:IMMD), continuing to build its intellectual property and leadership role in Beta Glucan technology, today announced that the Company recently received an issue notice from the U.S. Patent Office. ImmuDyne's patent application entitled, Methods of Purifying Beta Glucans (Amended), has now been issued as U.S. Patent 7,750,584.

ImmuDyne shares trade under the ticker symbol IMMD (PK) and the Company can be found on the web at www.immudyne.com

CONTACT:  ImmuDyne, Inc.
          Investors: 
          Mark McLaughlin
          1-914-714-8901 
          sales@immudyne.com

Other Company Press Releases

New Patent Issued to ImmuDyne by the U.S. Patent Office - Jun 30, 2009
Court of Appeals Upholds Judgment in ImmuDyne's Favor - Jun 23, 2009
ImmuDyne Announces Publication of New Cancer Study - Dec 10, 2008
ImmuDyne Pleased With Minnesota Court Decision - May 28, 2008
ImmuDyne Awarded Final Judgment Against Biothera and Byron Donzis/PSA Inc. - Mar 18, 2008
More >>

Stock Quote

Recent Quote for IMMD
Last Trade:	$ 0.17
Trade Time:	11/19/2009 ET
Change:	+0.00 (+0.000001%)
Prev Close:	0.17
52-Wk Range:	0.11 - 0.30